BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 15568145)

  • 1. P-selectin in arterial thrombosis.
    Merten M; Thiagarajan P
    Z Kardiol; 2004 Nov; 93(11):855-63. PubMed ID: 15568145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfatides activate platelets through P-selectin and enhance platelet and platelet-leukocyte aggregation.
    Merten M; Beythien C; Gutensohn K; Kühnl P; Meinertz T; Thiagarajan P
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):258-63. PubMed ID: 15528476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [P-selectin and its role in some diseases].
    Polek A; Sobiczewski W; Matowicka-Karna J
    Postepy Hig Med Dosw (Online); 2009 Oct; 63():465-70. PubMed ID: 19850970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated platelets induce Weibel-Palade-body secretion and leukocyte rolling in vivo: role of P-selectin.
    Dole VS; Bergmeier W; Mitchell HA; Eichenberger SC; Wagner DD
    Blood; 2005 Oct; 106(7):2334-9. PubMed ID: 15956287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PSGL-1 regulates platelet P-selectin-mediated endothelial activation and shedding of P-selectin from activated platelets.
    Dole VS; Bergmeier W; Patten IS; Hirahashi J; Mayadas TN; Wagner DD
    Thromb Haemost; 2007 Oct; 98(4):806-12. PubMed ID: 17938805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated, not resting, platelets increase leukocyte rolling in murine skin utilizing a distinct set of adhesion molecules.
    Ludwig RJ; Schultz JE; Boehncke WH; Podda M; Tandi C; Krombach F; Baatz H; Kaufmann R; von Andrian UH; Zollner TM
    J Invest Dermatol; 2004 Mar; 122(3):830-6. PubMed ID: 15086572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-selectin ligation induces platelet activation and enhances microaggregate and thrombus formation.
    Théorêt JF; Yacoub D; Hachem A; Gillis MA; Merhi Y
    Thromb Res; 2011 Sep; 128(3):243-50. PubMed ID: 21600632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role for sulfatides in platelet aggregation.
    Merten M; Thiagarajan P
    Circulation; 2001 Dec; 104(24):2955-60. PubMed ID: 11739312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet activation as a marker for in vivo prothrombotic activity: detection by flow cytometry.
    Tomer A
    J Biol Regul Homeost Agents; 2004; 18(2):172-7. PubMed ID: 15471223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-leukocyte aggregates and derived microparticles in inflammation, vascular remodelling and thrombosis.
    McGregor L; Martin J; McGregor JL
    Front Biosci; 2006 Jan; 11():830-7. PubMed ID: 16146774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-leukocyte interactions in thrombosis.
    Cerletti C; Tamburrelli C; Izzi B; Gianfagna F; de Gaetano G
    Thromb Res; 2012 Mar; 129(3):263-6. PubMed ID: 22075180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycoprotein IIb/IIIa inhibition reduces prothrombotic events under conditions of deep hypothermic circulatory arrest.
    Straub A; Azevedo R; Beierlein W; Wendel HP; Dietz K; Ziemer G
    Thromb Haemost; 2005 Jul; 94(1):115-22. PubMed ID: 16113794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P-selectin, tissue factor and CD40 ligand expression on platelet-leucocyte conjugates in the presence of a GPIIb/IIIa antagonist.
    Zhao L; Bath PM; May J; Lösche W; Heptinstall S
    Platelets; 2003; 14(7-8):473-80. PubMed ID: 14713516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of platelet P-selectin and formation of platelet-leukocyte aggregates in blood from patients treated with unfractionated heparin plus eptifibatide compared with bivalirudin.
    Keating FK; Dauerman HL; Whitaker DA; Sobel BE; Schneider DJ
    Thromb Res; 2006; 118(3):361-9. PubMed ID: 16139336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-selectin antagonism with recombinant p-selectin glycoprotein ligand-1 (rPSGL-Ig) inhibits circulating activated platelet binding to neutrophils induced by damaged arterial surfaces.
    Théorêt JF; Bienvenu JG; Kumar A; Merhi Y
    J Pharmacol Exp Ther; 2001 Aug; 298(2):658-64. PubMed ID: 11454928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A peptide from the staphylococcal protein Efb binds P-selectin and inhibits the interaction of platelets with leukocytes.
    Wallis S; Wolska N; Englert H; Posner M; Upadhyay A; Renné T; Eggleston I; Bagby S; Pula G
    J Thromb Haemost; 2022 Mar; 20(3):729-741. PubMed ID: 34846792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary and secondary capture of platelets onto inflamed femoral artery endothelium is dependent on P-selectin and PSGL-1.
    Braun OO; Slotta JE; Menger MD; Erlinge D; Thorlacius H
    Eur J Pharmacol; 2008 Sep; 592(1-3):128-32. PubMed ID: 18644365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil P-selectin-glycoprotein-ligand-1 binding to platelet P-selectin enhances metalloproteinase 2 secretion and platelet-neutrophil aggregation.
    Abou-Saleh H; Théorêt JF; Yacoub D; Merhi Y
    Thromb Haemost; 2005 Dec; 94(6):1230-5. PubMed ID: 16411399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet P-selectin plays an important role in arterial thrombogenesis by forming large stable platelet-leukocyte aggregates.
    Yokoyama S; Ikeda H; Haramaki N; Yasukawa H; Murohara T; Imaizumi T
    J Am Coll Cardiol; 2005 Apr; 45(8):1280-6. PubMed ID: 15837262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction.
    Michelson AD; Barnard MR; Krueger LA; Valeri CR; Furman MI
    Circulation; 2001 Sep; 104(13):1533-7. PubMed ID: 11571248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.